Member Info for stocksaint

They were getting the lab test results "within one week":

This involved developing a Taqman-based assay for relevant CYP2C19 variants (*2 *3 and *17) to NHS genetics laboratory standards. A clinical pathway was implemented for requesting tests at diagnosis of non-cardioembolic ischaemic cerebrovascular events, as well as follow-up reporting and communication with primary care. Some 98.9% of results were reported to the stroke team within one week.

And they've had projects doing lab testing for this already using the Thermo Fisher assay:

https://pharmaceutical-journal.com/article/opinion/lessons-from-testing-2300-patients-at-the-uks-first-clopidogrel-genotyping-system

Jimi, you're just surmising. I know the NHS were able to make HCV lab testing widespread from nothing in a fairly short timespan (and at one point HCV POC testing was GDR's big hope, going back about 7 years ago).

Jimi, if that was true surely a giant like Thermo Fisher wouldn't be offering a lab test for the stroke gene test.

Their best bet is RNR1. But I don't see big revenues until 2027. So they need to raise something like £12-15m before they breakeven in my view. Best bet for LTHs is probably to average down after (at) fundraisings I would say.

And running out of money in about 4 months...

You should ask GDR for a job, Jimi.

There's no analyst target anymore. That's just an old one from years ago.

I thought about reinvesting, but when I look back to the presentation, the wording GDR use is a bit concerning. When you look at near term outlook (within next 6 months), it not very clear what they'll get at all. And they should need another fund raise by end of May as things stand.

Lionel the clown

You're the one that should be banned.

I suppose it could take a while to write up the results if you're 20 and you drink about 5 beers a night. lol

It's possible, and obviously you're just guessing (but not making up quotes) though it seems quite ridiculous as well if you're right.

I doubt personally it would take them 6 months to write up the results of that data.

So where did you get that from? It doesn't say that in the article or the RNS

But for more up-to-date information, you can read about the 24-month study that will conclude in Autumn 2026 here:

https://healthinnovationmanchester.com/news/genetic-test-developed-by-manchester-researchers-to-prevent-newborn-babies-going-deaf-to-be-trialled-across-the-uk/

It doesn't have the quote "18 months evidence collection" in what you just posted.

This was a quote you entirely made up. The RNS text also refers to program. So I made up this new quote:

"18 months programme"

You absolute clown.

But neither source says both those things. One says 24 months. The other says 18.

I understand what desperation sounds like. It sounds like you.

It doesn't say anything about 18 months in the article. It just says "24-month study".

Lol Sledgey, you've been away a while: cash burn is now at £500k per month!